Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Brain Behav Immun. 2014 Aug 6;42:33–40. doi: 10.1016/j.bbi.2014.07.018

Table 4.

Relationships between measures of adiposity and IL-6 baseline and responses

IL-6 baseline
day 1		 IL-6 baseline
day 2		 IL-6 response
day 1		 IL-6 response
day 2
Body mass index (BMI) beta=0.41; p=0.001; R2 = 0.16 beta=0.34; p=0.011; R2 = 0.12 beta=0.09; p=0.50; R2 = 0.02 beta=0.27; p=0.044; R2 = 0.073
Body fat % beta=0.39; p=0.004; R2 = 0.13 beta=0.40; p=0.003; R2 = 0.16 beta=0.17; p=0.21; R2 = 0.03 beta=0.37; p=0.006; R2 = 0.13
Waist circumference beta=0.39; p=0.017; R2 = 0.09 beta=0.33; p=0.057; R2 = 0.08 beta=0.07; p=0.69; R2 = 0.01 beta=0.17; p=0.34; R2 = 0.02
Waist-to-hip ratio (WHR) beta=0.42; p=0.01; R2 = 0.10 beta=0.19; p=0.28; R2 = 0.04 beta=0.10; p=0.55; R2 = 0.02 beta=0.05; p=0.77; R2 = 0.01

All regression analyses controlled for age and sex in the first step; Neither age nor sex were significant predictors of baseline IL-6 concentrations except for sex on day 2 when including body fat in the model (all other p > 0.08); All regressions were significant also without controlling for age and sex.

All regression analyses controlled for age and sex in the first step; Neither age nor sex were significant predictors of IL-6 increases (all p > 0.28); All regressions were significant also without controlling for age and sex.